Warning letter
Allermed Laboratories Inc.: warning letter of Jun 3, 1998
FDA warning letter UCM066532 · Center for Biologics Evaluation and Research
Key facts
| Reference number | UCM066532 |
|---|---|
| Company | Allermed Laboratories Inc. |
| Subject | Deviation from Good Manufacturing Practice |
| Issue date | Jun 3, 1998 |
| Posted date | Jun 3, 1998 |
| Issuing office | Center for Biologics Evaluation and Research |
| Product type | Biologics |
| CFR sections cited | 21, 211, 211.56, 211.58, 211.68, 211.84, 211.42(c), 211.56(c), 211.94(b), 211.100(a), 211.113(b), 211.94 and 3 more |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: